| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |